重大事项：
联邦制药(03933)抗感染产品莫匹罗星软膏获批上市
上海医药(02607)：戊二酸利那拉生酯胶囊(X842 项目)上市许可申请获得批准
中国心连心化肥(01866)：6万吨聚甲醛项目已经竣工并进入试生产阶段
商汤-W(00020)：完成战略组织架构重组
越秀地产(00123)：拟10.92亿元出售广州宏城发展全部股权
美图公司(01357)已售出所持全部加密货币 获利约7963万美元
勇利投资(01145)获华建有限公司折让约8.83%提全购要约 12月5日复牌
经营业绩：
易鑫集团(02858)第三季度融资总额达185亿元 金融科技业务实现显著增长
碧桂园(02007)11月实现归属公司股东权益的合同销售金额约30.1亿元
信利国际(00732)前11个月累计综合营业净额约为162.63亿港元 同比增加约16.0%
景瑞控股(01862)前11个月累计合约签约销售额19.10亿元 同比减少46.41%
如需了解更多详情，请参阅智通财经网(www.zhitongcaijing.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.